References
- Gorbachova T, Melenevsky Y, Cohen M, et al. Osteochondral lesions of the knee: differentiating the most common entities at MRI. Radiographics. 2018;38(5):712–1495. 2018/09/01
- Wells D. Osteochondral Defect of the Knee [cited 2021 Sept 07]. Available from: https://www.atlasorthopaedics.com/osteochondral-defect-knee-orthopaedic-surgeon-woodstock-ga.html.
- Stanford Healthcare. Chondral/Osteochondral Defect [cited 2021 Sept 07]. Available from: https://stanfordhealthcare.org/medical-conditions/bones-joints-and-muscles/chondral-osteochondral-defect.html.
- Howell M, Liao Q, Gee CW. Surgical management of osteochondral defects of the knee: an educational review. Curr Rev Musculoskelet Med. 2021;14(1):60–66.
- Bruns J, Werner M, Habermann C. Osteochondritis dissecans: etiology, pathology, and imaging with a special focus on the knee joint. Cartilage. 2018;9(4):346–362.
- Gracitelli GC, Moraes VY, Franciozi CE, et al. Surgical interventions (microfracture, drilling, mosaicplasty, and allograft transplantation) for treating isolated cartilage defects of the knee in adults. Cochrane Database Syst Rev. 2016;9(9):Cd010675.
- Outerbridge RE. The etiology of chondromalacia patellae. J Bone Joint Surg Br. 1961;43-B:752–757.
- Henn RF 3rd, Gomoll AH. A review of the evaluation and management of cartilage defects in the knee. Phys Sportsmed. 2011;39(1):101–107.
- Pipino G, Risitano S, Alviano F, et al. Microfractures and hydrogel scaffolds in the treatment of osteochondral knee defects: a clinical and histological evaluation. J Clin Orthop Trauma. 2019;10(1):67–75.
- Stanish WD, McCormack R, Forriol F, et al. Novel scaffold-based BST-CarGel treatment results in superior cartilage repair compared with microfracture in a randomized controlled trial. J Bone Joint Surg Am. 2013;95(18):1640–1650.
- Shive MS, Stanish WD, McCormack R, et al. BST-CarGel® treatment maintains cartilage repair superiority over microfracture at 5 years in a multicenter randomized controlled trial. Cartilage. 2015;6(2):62–72.
- MEDICWAVE. JOINTREP™ Cartilage Regeneration Technology [cited 2021 Sept 07]. Available from: https://medicwave.com.my/jointrep/.
- Methot S, Changoor A, Tran-Khanh N, et al. Osteochondral biopsy analysis demonstrates that BST-CarGel treatment improves structural and cellular characteristics of cartilage repair tissue compared with Microfracture. Cartilage. 2016;7(1):16–28.
- Fravel J, Shaffer M. Rehabilitation following microfracture surgery 2011. [cited 2021 Sept 07]. Available from: https://lermagazine.com/article/rehabilitation-following-microfracture-surgery.
- Australian Government Department of Health. Prostheses List [cited 2021 Sept 07]. Available from: https://www.health.gov.au/resources/publications/prostheses-list.
- Australian Government Department of Health. Prostheses cover under private health insurance [cited 2021 Sept 07]. Available from: https://www.health.gov.au/health-topics/private-health-insurance/what-private-health-insurance-covers/prostheses-cover-under-private-health-insurance?utm_source=health.gov.au&utm_medium=callout-auto-custom&utm_campaign=digital_transformation.
- Australian Government. Private Health Insurance Act 2007 [cited 2021 Sept 07]. Available from: https://www.legislation.gov.au/Details/C2019C00067.
- Australian Government Department of Health, Therapeutic Goods Administration. Australian regulatory guidelines for medical devices (ARGMD) [cited 2021 Sept 07]. Available from: https://www.tga.gov.au/publication/australian-regulatory-guidelines-medical-devices-argmd.
- Australian Government Department of Health. Prostheses List Advisory Committee (PLAC) [cited 2021 Sept 07]. Available from: https://www.health.gov.au/committees-and-groups/prostheses-list-advisory-committee-plac.
- Medina J, Garcia-Mansilla I, Fabricant PD, et al. Microfracture for the treatment of symptomatic cartilage lesions of the knee: a survey of international cartilage regeneration & joint preservation society. Cartilage. 2021;13(1_suppl):1148S–1155S.
- Medical Services Advisory Committee Australia. Technical Guidelines for preparing assessment reports for the Medical Services Advisory Committee – Service Type: Investigative (Version 3.0). [cited 2021 Sept 07]. Available from: http://www.msac.gov.au/internet/msac/publishing.nsf/Content/0BD63667C984FEEACA25801000123AD8/$File/InvestigativeTechnicalGuidelines-December-2016-Version-3.0.pdf.
- The Pharmaceutical Benefits Advisory Committee Australia. Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee (Version 5.0). [cited 2021 Sept 07]. Available from: https://pbac.pbs.gov.au/content/information/files/pbac-guidelines-version-5.pdf.
- Australian Bureau of Statistics. Life tables [cited 2021 Nov 20]. Available from: https://www.abs.gov.au/statistics/people/population/life-tables/2018-2020.
- Fang WH, Huang GS, Chang HF, et al. Gender differences between WOMAC index scores, health-related quality of life and physical performance in an elderly Taiwanese population with knee osteoarthritis. BMJ Open. 2015;5(9):e008542.
- Pipino G, Risitano S, Alviano F, et al. Patient level data analyses from: microfractures and hydrogel scaffolds in the treatment of osteochondral knee defects: a clinical and histological evaluation. J Clin Orthop Trauma. 2019;10(1):67–75.
- Wailoo A, Hernandez Alava M, Escobar Martinez A. Modelling the relationship between the WOMAC osteoarthritis index and EQ-5D. Health Qual Life Outcomes. 2014;12:37.
- Viney R, Norman R, Brazier J, et al. An Australian discrete choice experiment to value eq-5d health states. Health Econ. 2014;23(6):729–742.
- Viney R, Norman R, King MT, et al. Time trade-off derived EQ-5D weights for Australia. Value Health. 2011;14(6):928–936.
- Clemens S, Begum N, Harper C, et al. A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA. Qual Life Res. 2014;23(8):2375–2381.
- McCaffrey N, Kaambwa B, Currow DC, et al. Health-related quality of life measured using the EQ-5D-5L: South Australian Population Norms. Health Qual Life Outcomes. 2016;14(1):133.
- Mather RC, 3rd, Hug KT, Orlando LA, et al. Economic evaluation of access to musculoskeletal care: the case of waiting for total knee arthroplasty. BMC Musculoskelet Disord. 2014;15:22.
- Frappier J, Stanish W, Brittberg M, et al. Economic evaluation of BST-CarGel as an adjunct to microfracture vs microfracture alone in knee cartilage surgery. J Med Econ. 2014;17(4):266–278.
- IHPA. National Hospital Cost Data Collection Report, Public Sector, Round 23 (Financial year 2018–19) [cited 2021 Sept 07]. Available from: https://www.ihpa.gov.au/publications/national-hospital-cost-data-collection-report-public-sector-round-23-financial-year.
- IHPA. National Efficient Price Determination 2021–22 [cited 2021 Sept 07]. Available from: https://www.ihpa.gov.au/publications/national-efficient-price-determination-2021-22.
- Australian Government Department of Health. Medicare Benefits Schedule Handbook. November 2021 [cited 2021 Sept 07]. Available from: http://www.mbsonline.gov.au/internet/mbsonline/publishing.nsf/Content/Downloads-211101.
- Australian Government Department of Health. Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) [cited 2021 Sept 07]. Available from: https://pbac.pbs.gov.au/.
- Australian Government Department of Health. Guidelines for preparing assessments for the MSAC [cited 2021 Sept 07]. Available from: http://www.msac.gov.au/internet/msac/publishing.nsf/Content/MSAC-Guidelines.
- Australian Government Department of Health. Prostheses List Guide [cited 2021 Sept 07]. Available from: https://www.health.gov.au/resources/publications/prostheses-list-guide.
- Pharmaceutical Benefits Scheme. OLAPARIB, 50 mg capsule, 4 x 112, Lynparza®, AstraZeneca Pty Ltd- Public Summary Document. March 2016. [cited 2021 Sept 07]. Available from: https://www.pbs.gov.au/industry/listing/elements/pbac-meetings/psd/2016-03/files/olaparib-psd-march-2016.pdf.
- Ebert JR, Fallon M, Zheng MH, et al. A randomized trial comparing accelerated and traditional approaches to postoperative weightbearing rehabilitation after matrix-induced autologous chondrocyte implantation: findings at 5 years. Am J Sports Med. 2012;40(7):1527–1537.
- Henderson IJ, Lavigne P. Periosteal autologous chondrocyte implantation for patellar chondral defect in patients with normal and abnormal patellar tracking. Knee. 2006;13(4):274–279.
- Henderson IJ, Tuy B, Connell D, et al. Prospective clinical study of autologous chondrocyte implantation and correlation with MRI at three and 12 months. J Bone Joint Surg Br. 2003;85(7):1060–1066.